Psychemedics (PMD) announces the appointment of Daniella Mehalik as its new Vice President – Finance. In her new role, Mehalik will assume responsibility for directing and managing all financial activities at Psychemedics, including comprehensive oversight of external reporting and internal analysis. Mehalik’s most recent position as Vice President and Controller at Neubase Therapeutics (NBSE) in Pittsburgh, PA, provides her with industry-specific insights crucial to Psychemedics’ operations.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on PMD:
- Psychemedics Corporation Appoints Daniella Mehalik as VP – Finance
- Psychemedics Corporation Reports Third Quarter 2023 Financial Results
- Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen
- Psychemedics launches Advanced 5-Panel Drug Screen
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue